Related Experiment Video
Updated: May 8, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Targeted therapy for squamous cell lung cancer
Rachel G Liao1, Hideo Watanabe, Matthew Meyerson
1Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA ; Cancer Program, Broad Institute, Cambridge, MA, USA.
Lung Cancer Management
|August 20, 2013
Summary
Lung squamous cell carcinoma (SqCC) treatment has lagged behind lung adenocarcinoma. Genomic studies are identifying promising therapeutic targets for SqCC, suggesting a future for targeted therapies in this cancer.
Area of Science:
- Oncology
- Genomics
- Biomarker Discovery
Background:
- Lung squamous cell carcinoma (SqCC) is a major cause of cancer death, with limited therapeutic advancements compared to lung adenocarcinoma.
- Recent progress in non-small cell lung cancer (NSCLC) management has focused on targeted therapies for molecularly defined subtypes like lung adenocarcinoma.
- Despite advances in other NSCLC subtypes, successful targeted therapies for SqCC remain elusive.
Purpose of the Study:
- To review current genomic characterization efforts in lung SqCC.
- To identify and validate potential therapeutic targets for SqCC.
- To explore the future of targeted therapies in SqCC treatment.
Main Methods:
- Review of ongoing genomic characterization studies in lung SqCC.
- Analysis of biomarker validation efforts.
- Synthesis of preclinical and clinical trial data.
Main Results:
- Genomic studies have nominated several promising therapeutic targets in lung SqCC.
- Biomarker validation efforts are underway to support targeted treatment strategies.
- These findings suggest a potential for successful targeted therapies in SqCC.
Conclusions:
- Targeted therapies show significant promise for the treatment of lung squamous cell carcinoma.
- Further investigation in preclinical models and clinical trials is warranted.
- Genomic insights are paving the way for personalized medicine in SqCC.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.